Flputnam Investment Management Co. Trims Stake in The Clorox Company $CLX

Flputnam Investment Management Co. lowered its stake in shares of The Clorox Company (NYSE:CLX) by 55.6% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 6,060 shares of the company’s stock after selling 7,574 shares during the period. Flputnam Investment Management Co.’s holdings in Clorox were worth $611,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Wilkins Investment Counsel Inc. increased its position in shares of Clorox by 250.6% during the fourth quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock valued at $5,552,000 after buying an additional 39,360 shares during the period. ProShare Advisors LLC increased its position in shares of Clorox by 11.7% during the third quarter. ProShare Advisors LLC now owns 1,297,016 shares of the company’s stock valued at $159,922,000 after buying an additional 136,135 shares during the period. JPMorgan Chase & Co. raised its holdings in Clorox by 27.0% in the third quarter. JPMorgan Chase & Co. now owns 928,654 shares of the company’s stock worth $114,506,000 after purchasing an additional 197,330 shares in the last quarter. Morningstar Investment Management LLC raised its holdings in Clorox by 131.8% in the fourth quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock worth $6,297,000 after purchasing an additional 35,506 shares in the last quarter. Finally, Swiss Life Asset Management Ltd raised its holdings in Clorox by 221.4% in the third quarter. Swiss Life Asset Management Ltd now owns 86,426 shares of the company’s stock worth $10,656,000 after purchasing an additional 59,533 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling

In other Clorox news, Director Pierre R. Breber acquired 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The shares were acquired at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. The trade was a 38.46% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.63% of the stock is owned by insiders.

Clorox Trading Down 6.5%

NYSE:CLX opened at $89.98 on Friday. The Clorox Company has a one year low of $84.70 and a one year high of $132.03. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The company’s 50-day simple moving average is $98.46 and its 200 day simple moving average is $105.81. The firm has a market capitalization of $10.88 billion, a P/E ratio of 14.61, a PEG ratio of 0.50 and a beta of 0.59.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same quarter in the previous year, the firm posted $1.45 earnings per share. Clorox’s quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, analysts forecast that The Clorox Company will post 5.61 EPS for the current fiscal year.

Analysts Set New Price Targets

CLX has been the topic of a number of research reports. UBS Group dropped their target price on shares of Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $91.00 target price on shares of Clorox in a research report on Friday, May 1st. Wall Street Zen raised shares of Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Jefferies Financial Group dropped their price objective on shares of Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Finally, Zacks Research lowered shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. One research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Reduce” and a consensus price target of $103.40.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.